Choline supplements in pregnancy: important nutrient, unsettled cognitive promise
Choline supports fetal development and liver function, but pregnancy trials report mixed child-cognition outcomes and products vary widely.

Adequate choline matters in pregnancy, while doubling intake or choosing a premium form does not guarantee a smarter child.
Choline is essential but not technically a vitamin
Choline contributes to cell membranes, acetylcholine, methyl-group metabolism, and lipid transport from the liver. The body can make some choline, but not always enough to meet needs. Eggs, meat, fish, dairy foods, soybeans, and some vegetables supply different choline compounds.
Most U.S. adults and pregnant women consume less than the Adequate Intake, yet frank deficiency is uncommon in healthy people. An intake below the Adequate Intake does not prove an individual is deficient because these population reference values carry substantial uncertainty.

Pregnancy creates a stronger rationale
Choline demand rises during pregnancy and lactation, when it supports placental function and fetal development. Prenatal vitamins often contain little choline because the nutrient is bulky, so diet becomes important. Folate, B12, methionine, and genetic variation interact with choline metabolism.
The established need for adequate choline is separate from claims that high-dose supplementation increases intelligence. Developmental outcomes depend on genetics, overall nutrition, health, environment, and education, and a small infant test cannot forecast a lifetime.
Two randomized trials reached different conclusions
A double-blind trial gave pregnant women phosphatidylcholine from 18 weeks through 90 days after birth. Infants did not differ from placebo on global development, language, or tested memory outcomes at 10 and 12 months.
A smaller controlled-feeding trial randomized 26 women in the third trimester to 480 or 930 milligrams of choline daily. Infants in the higher-intake group showed faster information-processing speed across several assessments. Tight dietary control strengthened exposure measurement, but the small sample limits certainty.
New reviews emphasize mixed evidence
A 2025 systematic review found that most neurodevelopmental outcomes from four randomized trials and five observational studies did not consistently support higher prenatal choline, although some measures favored supplementation. Different doses, forms, timing, tests, and follow-up ages made synthesis difficult.
This is a reasonable research signal, not a basis for guaranteed brain-development claims. Larger trials with prespecified outcomes, diverse participants, and longer follow-up are needed before an optimal dose above current recommendations can be established.

More choline has tradeoffs
High intakes can cause fishy body odor, vomiting, sweating, low blood pressure, and liver toxicity. The tolerable upper intake level is a safety ceiling, not a target. Choline metabolism by gut microbes can produce trimethylamine, later converted to TMAO, but the clinical meaning of altering TMAO through supplements remains unsettled.
Forms include choline bitartrate, phosphatidylcholine, citicoline, and alpha-GPC. They have different compositions and research uses. A trial of phosphatidylcholine in pregnancy cannot validate an alpha-GPC nootropic, and a brain-marketing claim cannot establish prenatal safety.
A practical prenatal approach
Estimate food intake, inspect the prenatal label, and discuss choline with prenatal care—especially with restricted diets, multiple gestation, nausea, or malabsorption. Do not replace folic acid with choline; the nutrients have interacting but distinct roles and evidence.
The balanced conclusion is neither that choline is unimportant nor that more is always better. Meeting nutritional needs is sensible, while claims about superior cognition require much stronger and more consistent evidence than the current pregnancy trials provide.
Applying the evidence
Choline is also marketed for adult memory through citicoline and alpha-GPC. Those nootropic questions involve different compounds, doses, and populations than prenatal nutrition. Results from stroke recovery or cognitive-impairment studies cannot be transferred to healthy students, and prenatal trials cannot validate an adult focus product.
People with trimethylaminuria can develop pronounced fishy odor because of impaired trimethylamine metabolism, making choline management specialized. Liver disease, parenteral nutrition, and genetic variants also change the context. These exceptions show why a nutrient with broad biological roles still needs a specific clinical question before supplementation.
Prenatal products face a practical formulation problem: hundreds of milligrams of choline occupy substantial capsule space. Some brands require several pills, while others list a small token amount. Compare milligrams rather than marketing claims, and count dietary sources before assuming the largest label is best. Tolerability and adherence matter throughout pregnancy.
Sources & further reading
This article is educational and does not diagnose, treat, or replace individual medical advice. Ask a qualified clinician or pharmacist about symptoms, medical conditions, and possible interactions before using supplements.